Bellevue Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,411	Closed	-$1.41M	–	178
2022 Q4	$1.41M	Sell	12,411 -289,439	-96%	-$24M	0.02%	131
2022 Q3	$18.7M	Sell	301,850 -35,584	-11%	-$2.49M	0.27%	84
2022 Q2	$26.9M	Sell	337,434 -7,666	-2%	-$726K	0.38%	70
2022 Q1	$36.3M	Sell	345,100 -23,500	-6%	-$2.29M	0.42%	72
2021 Q4	$39.7M	Sell	368,600 -47,600	-11%	-$5.19M	0.41%	74
2021 Q3	$45.6M	Sell	416,200 -1,500	-0.4%	-$156K	0.46%	67
2021 Q2	$39.1M	Buy	417,700 +9,200	+2%	+$847K	0.38%	82
2021 Q1	$37.6M	Buy	408,500 +28,300	+7%	+$2.39M	0.4%	83
2020 Q4	$27.8M	Buy	380,200 +302,800	+391%	+$22.5M	0.32%	83
2020 Q3	$6.01M	Sell	77,400 -80,800	-51%	-$5.56M	0.08%	123
2020 Q2	$8.79M	Sell	158,200 -7,800	-5%	-$334K	0.12%	114
2020 Q1	$4.92M	Sell	166,000 -149,700	-47%	-$5.06M	0.1%	113
2019 Q4	$11.4M	Sell	315,700 -7,600	-2%	-$233K	0.18%	86
2019 Q3	$8.8M	Buy	323,300 +54,800	+20%	+$1.42M	0.16%	93
2019 Q2	$6.46M	Buy	268,500 +109,700	+69%	+$2.78M	0.11%	101
2019 Q1	$4.2M	Sell	158,800 -9,700	-6%	-$230K	0.23%	83
2018 Q4	$3.29M	Sell	168,500 -53,178	-24%	-$1.04M	0.22%	84
2018 Q3	$4.34M	Buy	221,678 +30,100	+16%	+$572K	0.28%	77
2018 Q2	$3.17M	Buy	+191,578	New	+$2.92M	0.27%	72
2018 Q1	–	Sell	-794,062	Closed	-$11.6M	–	137
2017 Q4	$11.6M	Buy	794,062 +307,599	+63%	+$4.32M	1.21%	34
2017 Q3	$6.17M	Buy	486,463 +79,065	+19%	+$1.01M	0.65%	49
2017 Q2	$4.84M	Sell	407,398 -91,367	-18%	-$1.14M	0.57%	58
2017 Q1	$7.37M	Buy	498,765 +474,765	+1,978%	+$7.69M	0.98%	38
2016 Q4	$388K	Sell	24,000 -93,000	-79%	-$1.69M	0.08%	114
2016 Q3	$2.12M	Hold	117,000	–	–	0.38%	73
2016 Q2	$1.93M	Sell	117,000 -193,000	-62%	-$3.12M	0.36%	73
2016 Q1	$5.14M	Buy	+310,000	New	+$5.42M	0.93%	39